Company news
CorMedix Inc. news in 2024
CorMedix Inc.'s news releases, calls and decks from 2024, newest first.
CorMedix Inc. Added to Nasdaq Biotechnology Index
December 18, 2024
CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products
November 25, 2024
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
November 3, 2024
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update
October 29, 2024
CorMedix Inc. Announces New Data at ASN Kidney Week 2024
October 23, 2024
CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024
October 22, 2024
CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator
October 7, 2024
CorMedix Inc. Announces New Commercial Agreement
September 18, 2024
CorMedix Inc. to Present at the Cantor Global Healthcare Conference
September 12, 2024
CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update
August 13, 2024
CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024
August 6, 2024
CorMedix Inc. Announces Outpatient Availability of DefenCath
July 2, 2024
CorMedix Inc. Receives FDA Feedback on Potential Label Expansion
June 17, 2024
CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath
June 5, 2024
CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider
May 27, 2024
CorMedix Inc. to Participate in Two Upcoming Investor Conferences
May 9, 2024
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
May 8, 2024
CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024
May 5, 2024
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
April 18, 2024
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
April 14, 2024
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
April 10, 2024
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
April 7, 2024
CorMedix Inc. to Present at the Needham Annual Healthcare Conference
March 26, 2024
CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 11, 2024
CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024
March 5, 2024
CorMedix Inc. Announces Commercial and Reimbursement Updates
January 29, 2024
CorMedix Inc. Announces Commercial and Operational Updates
January 7, 2024
Calls in 2024
Decks in 2024
- Investor Presentation (August 2024)
Investor deck · 32 slides · Aug 14, 2024